VFY

VITRAFY LIFE SCIENCE

• ASX·1d ago

  USAISR Completes Phase 2 Platelet Study

• ASX·03/25 21:15

  NWR Virtual Healthcare Conference Presentation

• ASX·03/24 06:41

  Vitrafy to present at NWR Virtual Healthcare Conference

• Dow Jones·03/23 21:32

  *Vitrafy Life Sciences Price Target Cut 4% to A$2.40/Share by Ord Minnett

• ASX·02/19 00:10

  Change of Director's Interest Notice

• Dow Jones·02/15 20:30

  *Vitrafy Life Sciences Price Target Raised 8.7% to A$2.50/Share by Ord Minnett

• Dow Jones·02/04 21:57

  *Vitrafy Life Sciences Price Target Cut 1.3% to A$2.25/Share by Bell Potter

• The Motley Fool·02/04 20:30

  Why this ASX healthcare stock is a speculative buy

• ASX·02/03 21:27

  FY26 Half Year Results Presentation

• ASX·02/03 21:27

  FY26 Appendix 4D and Half Year Report

• ASX·02/02 21:21

  Vitrafy FY26 Half Year Investor Briefing

• Dow Jones·01/29 22:57

  *Vitrafy Life Sciences Price Target Raised 8.6% to A$2.28/Share by Bell Potter

• The Motley Fool·01/29 21:07

  This broker just upgraded this ASX healthcare stock and is predicting 30% upside

• ASX·01/28 21:19

  Q2 FY26 Quarterly Activities Report and Appendix 4C

• ASX·01/28 21:19

  Quarterly Investor Briefing Presentation